Abstract
At the recent 2018 PGDIS congress, a review of randomized controlled trials of preimplantation genetic testing for aneuploidies (PGT-A) showed improved ongoing pregnancy rates per transfer in experienced centres and in women aged 35 years and older. Young women produce 40% abnormal embryos (20-60% range), but not all centres see a selection advantage; this indicates the need for more emphasis in improving biopsy and case management. Some chromosome abnormalities are iatrogenic; PGT-A could, therefore, be used as assisted reproductive technology (ART) quality control. Great improvements in non-invasive PGT by testing spent media have been reported, ranging from 80-95% concordance with trophectoderm biopsy, probably precluding the need for biopsy soon. Mosaicism was widely discussed, with PGDIS agreeing to update their guidelines, but continuing to recommend prioritizing euploid, followed by mosaic embryos. Techniques to allow simultaneous single sample analysis of aneuploidy and inherited mutations are improving, but this does not extend to de-novo mutations. Convincing data were presented on the efficacy of using endometrial receptivity tests to improve ART outcomes adjuvant or independently of PGT-A. Imprinting, CRISPR and clo...Continue Reading
Citations
Feb 28, 2019·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Hayden Anthony Homer
Apr 18, 2019·Systems Biology in Reproductive Medicine·Michał KunickiKrzysztof Łukaszuk
Mar 6, 2019·Prenatal Diagnosis·Dagan WellsJoe Leigh Simpson
Feb 28, 2020·Acta Obstetricia Et Gynecologica Scandinavica·Julius HreinssonHans Jakob Ingerslev
Feb 28, 2020·Journal of Assisted Reproduction and Genetics·Tianxiang NiZi-Jiang Chen
Dec 20, 2019·PloS One·Helena KaiholaHelena Åkerud
May 1, 2020·Scientific Reports·Valeriy KuznyetsovClifford L Librach
Jul 12, 2019·Frontiers in Endocrinology·Wenhao ShiJuanzi Shi
Aug 16, 2019·Journal of Translational Medicine·Federica CariatiRossella Tomaiuolo
Mar 4, 2020·Scientific Reports·Nicholas M MurphyLuk J F Rombauts
Jul 28, 2020·Biology·Jordi Ribas-MaynouAlbert Salas-Huetos
Oct 11, 2019·The CRISPR Journal·Manuel ViottiFrank L Barnes
Dec 16, 2019·Journal of Assisted Reproduction and Genetics·Xinyuan LiPing Zhou
Sep 26, 2020·Journal of Assisted Reproduction and Genetics·Mauro CozzolinoNicolas Garrido
Dec 15, 2020·Human Reproduction·Reeva MakhijaniLawrence Engmann
Feb 12, 2021·PloS One·Akihiro ShitaraYukihiro Terada
Feb 14, 2021·Fertility and Sterility·Sonia M Suter
Feb 6, 2021·Obstetrics and Gynecology·Elias M Dahdouh
Feb 20, 2021·Reproductive Biology and Endocrinology : RB&E·Norbert GleicherUNKNOWN International Do No Harm Group in IVF (IDNHG-IVF)
May 18, 2020·Reproductive Biomedicine Online·Sophie BrouilletSamir Hamamah
Nov 2, 2020·American Journal of Obstetrics and Gynecology·Mengmeng LiValerie L Baker
Jun 11, 2021·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Hayden Anthony Homer
Jun 30, 2021·Scientific Reports·M EncisoJ Sarasa
Jul 16, 2021·Reproductive Medicine and Biology·Hiroomi KawanoNaomi Kashiwazaki
Jul 5, 2021·Archives of Gynecology and Obstetrics·Yunni CaiJianjun Zhou